Tag Archives: statin therapy
September 2008 Br J Cardiol 2008;15:231-36
News from the 2008 Congress of the European Society of Cardiology
BJCardio editorial team
GISSI-HF shows benefit for PUFA in heart failure Two new studies from the Italian GISSI group show that n-3 polyunsaturated fatty acids (PUFA) supplementation improves morbidity and mortality in those with symptomatic heart failure, but statins don’t have any benefit in the same type of patients. The results were presented during a hotline session at the Congress and published simultaneously in The Lancet (Lancet 2008; DOI:10.1016/S0140-6736[08]61239-8, and Lancet 2008;DOI:10.1016/S0140-6736[08]61240-4). Long-term administration of PUFA reduced all-cause mortality by 9%, which the investigators say was a modest effect, and they also cut
July 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 38–AIC 40
Statin therapy following percutaneous coronary revascularisation: time to make LIPS stick?
Arun Natarajan, Scott A Gall, Azfar Zaman
No content available
April 2002 Br J Cardiol 2002;9:193-4
Statins: myalgia and myositis
Anthony S Wierzbicki
No content available
For healthcare professionals only
